THE WHAT? Chinese collagen tech start-up, Trautec Medical Technology has raised CNY200 million in a Series B funding round led by L Catterton’s first Chinese yuan fund and CLSA Asset Management.

THE DETAILS According to Yicai, the investment follows a CNY200 million Series A round, led by Shiseido’s Beauty Innovations Fund.

THE WHY? Chen Yue, Managing Partner, L Catterton, told Yicai, “L Catterton looks forward to leveraging the investment experience and industry resources accumulated in the global beauty and personal care market over the past 30 years to help target companies build up business cooperation opportunities with international skin care brands and channels.”